• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ACE2-enriched extracellular vesicles enhance infectivity of live SARS-CoV-2 virus.

作者信息

Tey Sze Keong, Lam Hoiyan, Wong Samuel Wan Ki, Zhao Hanjun, To Kelvin Kai-Wang, Yam Judy Wai Ping

机构信息

Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Pokfulam, People's Republic of China.

School of Biological Sciences, College of Science, Nanyang Technological University, Singapore, Singapore.

出版信息

J Extracell Vesicles. 2022 May;11(5):e12231. doi: 10.1002/jev2.12231.

DOI:10.1002/jev2.12231
PMID:35582880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9115585/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c627/9115585/de8d2a42dc85/JEV2-11-e12231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c627/9115585/97461e2b63dd/JEV2-11-e12231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c627/9115585/de8d2a42dc85/JEV2-11-e12231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c627/9115585/97461e2b63dd/JEV2-11-e12231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c627/9115585/de8d2a42dc85/JEV2-11-e12231-g002.jpg

相似文献

1
ACE2-enriched extracellular vesicles enhance infectivity of live SARS-CoV-2 virus.富含血管紧张素转换酶2的细胞外囊泡增强活的严重急性呼吸综合征冠状病毒2病毒的感染性。
J Extracell Vesicles. 2022 May;11(5):e12231. doi: 10.1002/jev2.12231.
2
Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.血管紧张素转换酶 2（ACE2）在 COVID-19 所致急性呼吸窘迫综合征发病机制中的作用。
Front Immunol. 2021 Dec 22;12:732690. doi: 10.3389/fimmu.2021.732690. eCollection 2021.
3
The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.hACE2 受体蛋白的表达及其在 SARS-CoV-2 进入、发病机制中的作用及其作为潜在治疗靶点的应用。
Tumour Biol. 2021;43(1):177-196. doi: 10.3233/TUB-200084.
4
Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.新型冠状病毒肺炎与血管紧张素转换酶 2 的关系：范围综述。
Adv Exp Med Biol. 2021;1321:53-68. doi: 10.1007/978-3-030-59261-5_5.
5
Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity.关于支持人细胞膜结合型ACE2的必要性及反对可溶性ACE2对SARS-CoV-2感染性作用的证据的回应。
Cell. 2022 May 26;185(11):1840-1841. doi: 10.1016/j.cell.2022.05.005.
6
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.SARS-COV-2 刺突糖蛋白的优化假型条件。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.01062-20.
7
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.竞争性 SARS-CoV-2 血清学研究表明，大多数针对刺突受体结合域的抗体竞争与 ACE2 结合。
mSphere. 2020 Sep 16;5(5):e00802-20. doi: 10.1128/mSphere.00802-20.
8
Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突糖蛋白Y217N突变对病毒与血管紧张素转换酶2（ACE2）亲和力的无影响。
J Biol Chem. 2021 Jan-Jun;296:100725. doi: 10.1016/j.jbc.2021.100725. Epub 2021 May 27.
9
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.ACE2 表达中的遗传变异性对 SARS-CoV-2 刺突 D614G 突变进化动态的影响。
Genes (Basel). 2020 Dec 24;12(1):16. doi: 10.3390/genes12010016.
10
Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.截短的人血管紧张素转换酶2；一种潜在的严重急性呼吸综合征冠状病毒2刺突糖蛋白抑制剂和有效的2019冠状病毒病治疗剂。
J Biomol Struct Dyn. 2021 Jul;39(10):3605-3614. doi: 10.1080/07391102.2020.1768150. Epub 2020 May 20.

引用本文的文献

1
Quantitative characterisation of extracellular vesicles designed to decoy or compete with SARS-CoV-2 reveals differential mode of action across variants of concern and highlights the diversity of Omicron.旨在与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）诱饵或竞争的细胞外囊泡的定量表征揭示了针对不同关注变体的不同作用模式，并突出了奥密克戎的多样性。
Cell Commun Signal. 2025 Jul 2;23(1):323. doi: 10.1186/s12964-025-02223-x.
2
Comparative Examination of Feline Coronavirus and Canine Coronavirus Effects on Extracellular Vesicles Acquired from A-72 Canine Fibrosarcoma Cell Line.猫冠状病毒和犬冠状病毒对源自A-72犬纤维肉瘤细胞系的细胞外囊泡影响的比较研究
Vet Sci. 2025 May 15;12(5):477. doi: 10.3390/vetsci12050477.
3

本文引用的文献

1
Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID-19 Therapy.工程化富含棕榈酰化 ACE2 的细胞外囊泡作为 COVID-19 治疗方法。
Adv Mater. 2021 Dec;33(49):e2103471. doi: 10.1002/adma.202103471. Epub 2021 Oct 19.
2
Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles.使用工程化的ACE2细胞外囊泡中和严重急性呼吸综合征冠状病毒2（SARS-CoV-2）假病毒
Acta Pharm Sin B. 2022 Mar;12(3):1523-1533. doi: 10.1016/j.apsb.2021.09.004. Epub 2021 Sep 9.
3
The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum.
Viral Membrane-Targeting Amphipathic Helical Peptide-Based Fluorogenic Probes for the Analysis of Infectious Titers of Enveloped Viruses.
用于分析包膜病毒感染滴度的基于病毒膜靶向两亲性螺旋肽的荧光探针
Anal Chem. 2025 Mar 18;97(10):5480-5487. doi: 10.1021/acs.analchem.4c04852. Epub 2025 Jan 22.
4
Circulating extracellular vesicles from severe COVID-19 patients induce lung inflammation.严重 COVID-19 患者的循环细胞外囊泡诱导肺部炎症。
mSphere. 2024 Nov 21;9(11):e0076424. doi: 10.1128/msphere.00764-24. Epub 2024 Oct 30.
5
Feline coronavirus influences the biogenesis and composition of extracellular vesicles derived from CRFK cells.猫冠状病毒影响源自猫肾传代细胞（CRFK细胞）的细胞外囊泡的生物发生和组成。
Front Vet Sci. 2024 Jul 18;11:1388438. doi: 10.3389/fvets.2024.1388438. eCollection 2024.
6
The Proteome of Extracellular Vesicles Released from Pulmonary Microvascular Endothelium Reveals Impact of Oxygen Conditions on Biotrauma.肺微血管内皮细胞释放的细胞外囊泡蛋白质组揭示了氧条件对生物创伤的影响。
Int J Mol Sci. 2024 Feb 19;25(4):2415. doi: 10.3390/ijms25042415.
7
Extracellular Vesicles and Their Role in Lung Infections.细胞外囊泡及其在肺部感染中的作用。
Int J Mol Sci. 2023 Nov 9;24(22):16139. doi: 10.3390/ijms242216139.
8
Trick-or-Trap: Extracellular Vesicles and Viral Transmission.诱骗还是陷阱：细胞外囊泡与病毒传播
Vaccines (Basel). 2023 Sep 27;11(10):1532. doi: 10.3390/vaccines11101532.
9
Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy.红细胞衍生的细胞外囊泡显示出内源性抗病毒作用，并增强抗病毒寡核苷酸治疗的效果。
ACS Nano. 2023 Nov 14;17(21):21639-21661. doi: 10.1021/acsnano.3c06803. Epub 2023 Oct 18.
10
Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update.新型冠状病毒肺炎预后、治疗和疫苗接种中外泌体的研究进展。
Appl Microbiol Biotechnol. 2023 Apr;107(7-8):2131-2141. doi: 10.1007/s00253-023-12468-6. Epub 2023 Mar 14.
刺突 N501Y 突变对 SARS-CoV-2 恢复期血清中和活性和 RBD 结合的影响。
EBioMedicine. 2021 Sep;71:103544. doi: 10.1016/j.ebiom.2021.103544. Epub 2021 Aug 19.
4
Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9.通过活细胞内追踪 CD63 和 CD9 揭示外泌体与小细胞外囊泡分泌的特异性。
Nat Commun. 2021 Jul 19;12(1):4389. doi: 10.1038/s41467-021-24384-2.
5
Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.细胞外囊泡携带 SARS-CoV-2 刺突蛋白，并充当中和抗体的诱饵。
J Extracell Vesicles. 2021 Jun;10(8):e12112. doi: 10.1002/jev2.12112. Epub 2021 Jun 18.
6
Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19.细胞模拟纳米诱捕器中和 SARS-CoV-2 并减轻 COVID-19 非人灵长类动物模型中的肺损伤。
Nat Nanotechnol. 2021 Aug;16(8):942-951. doi: 10.1038/s41565-021-00923-2. Epub 2021 Jun 17.
7
Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection.用病毒刺突蛋白的 RBD 对细胞外囊泡进行标记，以递呈抗病毒药物来对抗 SARS-CoV-2 感染。
J Control Release. 2021 Jul 10;335:584-595. doi: 10.1016/j.jconrel.2021.05.049. Epub 2021 Jun 3.
8
The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.干扰素刺激的细胞外体 hACE2 通过竞争性阻断病毒进入来有效抑制 SARS-CoV-2 复制。
Signal Transduct Target Ther. 2021 May 12;6(1):189. doi: 10.1038/s41392-021-00604-5.
9
Emerging roles of extracellular vesicles in COVID-19, a double-edged sword?细胞外囊泡在 COVID-19 中的新兴作用：一把双刃剑？
Immunology. 2021 Aug;163(4):416-430. doi: 10.1111/imm.13329. Epub 2021 May 4.
10
Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.可溶性 ACE2 通过与肾素-血管紧张素系统相关蛋白的相互作用介导 SARS-CoV-2 的细胞进入。
Cell. 2021 Apr 15;184(8):2212-2228.e12. doi: 10.1016/j.cell.2021.02.053. Epub 2021 Mar 2.